Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUF) Sees Large Growth in Short Interest

Sumitomo Pharma Co., Ltd. (OTCMKTS:DNPUFGet Free Report) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totalling 10,876,900 shares, a growth of 8.1% from the March 31st total of 10,057,800 shares. Based on an average daily trading volume, of 0 shares, the short-interest ratio is currently ∞ days.

Sumitomo Pharma Price Performance

OTCMKTS DNPUF opened at $2.70 on Thursday. Sumitomo Pharma has a fifty-two week low of $2.27 and a fifty-two week high of $6.21. The firm’s fifty day moving average price is $2.45 and its two-hundred day moving average price is $2.84.

Sumitomo Pharma Company Profile

(Get Free Report)

Sumitomo Pharma Co, Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. The company offers pharmaceutical products, such as therapeutic agents for Parkinson's disease, uterine fibroids, depression, type 2 diabetes, systemic fungal infection, hypertension, pruritus, advanced prostate cancer, overactive bladder, chronic obstructive pulmonary disease, angina pectoris, and arrhythmia.

Further Reading

Receive News & Ratings for Sumitomo Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sumitomo Pharma and related companies with MarketBeat.com's FREE daily email newsletter.